Molecular classification of human carcinomas by use of gene expression signatures.
暂无分享,去创建一个
J. Welsh | L. Sapinoso | A. Su | S. Kern | C. Moskaluk | H. Frierson | G. Hampton | P. Schultz | H. Lapp | P. Dimitrov | S. Powell | Peter G. Schultz | Peter G Schultz
[1] M. Stone. Cross‐Validatory Choice and Assessment of Statistical Predictions , 1976 .
[2] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[3] Robert Tibshirani,et al. An Introduction to the Bootstrap , 1994 .
[4] D. Lockhart,et al. Expression monitoring by hybridization to high-density oligonucleotide arrays , 1996, Nature Biotechnology.
[5] L. Old,et al. Enhanced antitumor activity of combination radioimmunotherapy (131I-labeled monoclonal antibody A33) with chemotherapy (fluorouracil). , 1997, Cancer research.
[6] L. Wodicka,et al. Genome-wide expression monitoring in Saccharomyces cerevisiae , 1997, Nature Biotechnology.
[7] S. Korourian,et al. Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[8] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[9] L. Greller,et al. Detecting selective expression of genes and proteins. , 1999, Genome research.
[10] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[11] T. Sun,et al. Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder. , 1999, The Journal of urology.
[12] G. Yousef,et al. Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma. , 2000, Clinical biochemistry.
[13] I. Pastan,et al. Anti-Tumor Activity of K1-LysPE38QQR, an Immunotoxin Targeting Mesothelin, a Cell-Surface Antigen Overexpressed in Ovarian Cancer and Malignant Mesothelioma , 2000, Journal of immunotherapy.
[14] Nello Cristianini,et al. Support vector machine classification and validation of cancer tissue samples using microarray expression data , 2000, Bioinform..
[15] H. Hillen. Unknown primary tumours , 2000, Postgraduate medical journal.
[16] Vladimir N. Vapnik,et al. The Nature of Statistical Learning Theory , 2000, Statistics for Engineering and Information Science.
[17] R. Ghossein,et al. Molecular detection of micrometastases and circulating tumor cells in melanoma prostatic and breast carcinomas. , 2000, In vivo.
[18] J. Reis-Filho,et al. Is TTF1 a good immunohistochemical marker to distinguish primary from metastatic lung adenocarcinomas? , 2000, Pathology, research and practice.
[19] D. Lockhart,et al. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[20] J. Welsh,et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. , 2001, Cancer research.
[21] M. Ringnér,et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks , 2001, Nature Medicine.
[22] Taylor Murray,et al. Cancer Statistics, 2001 , 2001, CA: a cancer journal for clinicians.
[23] Sayan Mukherjee,et al. Molecular classification of multiple tumor types , 2001, ISMB.
[24] E. Dougherty,et al. Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.